| Kidney and Blood Pressure Research | |
| The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy | |
| Caliskan Y.1  Oztop N.3  Aksoy A.3  Kilicaslan I.2  Sever M.S.1  Celik D.1  Ucar A.S.1  Ozluk Y.2  Yazici H.1  | |
| [1] Division of Nephrology, Department of Internal Medicine, $$;Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey$$ | |
| 关键词: Biomarkers; Complement; End stage renal disease; IgA Nephropathy; Uric acid; | |
| DOI : 10.1159/000443415 | |
| 来源: S Karger AG | |
PDF
|
|
【 摘 要 】
Background/Aims: The aim of this study is to investigate the utility of clinical [age, gender, mean arterial pressure (MAP)] and laboratory parameters [eGFR, hemoglobin (Hgb), serum levels of creatinine, uric acid, albumin, proteinuria, hematuria] and also histopathological lesions (Oxford classification parameters, crescents, intensity and pattern of staining for C3, C1Q, IgA, IgG, IgM) as progression markers in patients with IgA Nephropathy (IgAN). Methods: A total of 111 IgAN patients with a follow-up period >1 year or who reached kidney failure [GFR category G5 chronic kidney disease (CKD)] <1 year were investigated. Primary endpoint was the development of kidney failure or eGFR decline ≥50% from the baseline. Kaplan-Meier and Cox proportional hazards analyses were performed. Results: Mean follow-up period was 33±29 months. Thirty-seven (33.3%) patients progressed to kidney failure and 4 (3.6%) patients developed eGFR decline ≥50% from the baseline after a median of 23 and 65 months, respectively. In multivariate Cox regression analysis, baseline levels of Hgb (HR:0.782, 95% CI 0.559-0.973, p=0.037), serum uric acid (HR:1.293, 95% CI 1.023-1.621, p=0.046), eGFR (HR:0.966, 95% CI 0.947-0.984, p=0.004) and intensity of C3 staining (HR:1.550, 95% CI 1.198-1.976, p=0.049) predicted primary endpoint. Serum uric acid level was associated independently with T score (β=0.303, p=0.005) in patients with eGFR>30 ml/min/m2. Conclusions: Hyperuricemia and the deposition of C3 are independent risk factors for IgAN progression.
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201912040499681ZK.pdf | 1574KB |
PDF